Literature DB >> 9645502

Structure and function of the plasma phospholipid transfer protein.

L Lagrost1, C Desrumaux, D Masson, V Deckert, P Gambert.   

Abstract

Recent cloning and sequencing of plasma phospholipid transfer protein complementary DNA revealed that phospholipid transfer protein belongs to the lipid transfer/lipopolysaccharide binding protein family that includes the cholesteryl ester transfer protein, the bactericidal permeability increasing protein and the lipopolysaccharide-binding protein. In addition to structural similarities, members of the lipid transfer/lipopolysaccharide-binding protein family might share some common functional properties, and recent studies demonstrated that phospholipid transfer protein can act in several distinct metabolic processes. In particular, the molecular transfer of phospholipids, unesterified cholesterol, alpha-tocopherol and lipopolysaccharides by phospholipid transfer protein suggests that it might be involved both in lipoprotein metabolism and in antimicrobial defence, resulting in a growing interest in this protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645502     DOI: 10.1097/00041433-199806000-00004

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  10 in total

1.  Role of cysteine residues in human plasma phospholipid transfer protein.

Authors:  S J Qu; H Z Fan; C Kilinc; H J Pownall
Journal:  J Protein Chem       Date:  1999-02

2.  Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate.

Authors:  Y Weinrauch; S S Katz; R S Munford; P Elsbach; J Weiss
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 3.  High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis.

Authors:  M A Kawashiri; C Maugeais; D J Rader
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

4.  Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass.

Authors:  Marius R Robciuc; Jari Metso; Anca Sima; Christian Ehnholm; Matti Jauhiainen
Journal:  Lipids Health Dis       Date:  2010-06-09       Impact factor: 3.876

5.  Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes.

Authors:  Yi Luo; Lorraine Shelly; Thomas Sand; Benjamin Reidich; George Chang; Mary Macdougall; Marie-Claire Peakman; Xian-Cheng Jiang
Journal:  J Pharmacol Exp Ther       Date:  2009-11-20       Impact factor: 4.030

Review 6.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

7.  PLTP is present in the nucleus, and its nuclear export is CRM1-dependent.

Authors:  Simona Vuletic; Weijiang Dong; Gertrud Wolfbauer; Joseph R Day; John J Albers
Journal:  Biochim Biophys Acta       Date:  2009-01-24

8.  Plasma lipases and lipid transfer proteins increase phospholipid but not free cholesterol transfer from lipid emulsion to high density lipoproteins.

Authors:  V S Nunes; E C Quintão; P M Cazita; L M Harada; E C de Faria; H C Oliveira
Journal:  BMC Biochem       Date:  2001-02-20       Impact factor: 4.059

9.  Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.

Authors:  Valérie Deckert; Stéphanie Lemaire; Pierre-Jean Ripoll; Jean-Paul Pais de Barros; Jérôme Labbé; Caroline Chabert-Le Borgne; Véronique Turquois; Guillaume Maquart; Delphine Larose; Nicolas Desroche; Franck Ménétrier; Naig Le Guern; Lorène J Lebrun; Catherine Desrumaux; Thomas Gautier; Jacques Grober; Charles Thomas; David Masson; Louis-Marie Houdebine; Laurent Lagrost
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

10.  The structure of latherin, a surfactant allergen protein from horse sweat and saliva.

Authors:  Steven J Vance; Rhona E McDonald; Alan Cooper; Brian O Smith; Malcolm W Kennedy
Journal:  J R Soc Interface       Date:  2013-06-19       Impact factor: 4.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.